Intravenous infusion of DMT

Phase 1Small molecule

UUniversity Hospital, Basel, Switzerland

Intravenous infusion of DMT is one of 4 small molecule programs targeting Experimental. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ExperimentalRecruiting

ExperimentalPhase 1

Recruiting

Competition

Competitive Landscape

7 competitors in Experimental

#DrugCompanyPhaseTrials

Active Ethanol

YYale University

Phase 1

1 2

Intravenous infusion of DMT

UUniversity Hospital, Basel, Switzerland

Phase 1

1 3

Potassium Nitrate

GSK

Preclinical

1 4

Nalbuphine Plus Naloxone

UUniversity of California, San Francisco

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Experimental1 trial

Acute Analgesic Effects of DMT on Experimentally Induced Pain in Healthy Participants

Recruiting·UUniversity Hospital, Basel, Switzerland·Phase 1·NCT06180759·18 enrolled

Mortality1 trial

TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality

Completed·UUniversity Hospital, Basel, Switzerland·Phase 4·NCT00286585·385 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Intravenous infusion of DMT. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Intravenous infusion of DMT compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Intravenous infusion of DMT. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Basel, Switzerland company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: UUniversity Hospital, Basel, Switzerland

Intravenous infusion of DMT

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Experimental1 trial

Mortality1 trial

References

Drug Info

Quick Facts

Related News